title: In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury.
abstract: The cardioprotective effects of an mAb to P-selectin designated mAb PB1.3 was examined in a feline model of myocardial ischemia (MI) and reperfusion. PB1.3 (1 mg/kg), administered after 80 min of ischemia (i.e., 10 min before reperfusion), significantly attenuated myocardial necrosis compared to a non-blocking mAb (NBP1.6) for P-selectin (15 +/- 3 vs 35 +/- 3% of area at risk, P < 0.01). Moreover, endothelial release of endothelium derived relaxing factor, as assessed by relaxation to acetylcholine, was also significantly preserved in ischemic-reperfused coronary arteries isolated from cats treated with mAb PB1.3 compared to mAb NBP1.6 (67 +/- 6 vs 11 +/- 3, P < 0.01). This endothelial preservation was directly related to reduced endothelial adherence of PMNs in ischemic-reperfused coronary arteries. Immunohistochemical localization of P-selectin was significantly upregulated in the cytoplasm of endothelial cells that lined coronary arteries and veins after 90 min of ischemia and 20 min of reperfusion. The principal site of intracytoplasmic expression was in venous vessels. mAb PB1.3 significantly decreased (P < 0.01) adherence of unstimulated PMNs to thrombin and histamine stimulated endothelial cells in a concentration-dependent manner in vitro. These results demonstrate that PMN adherence to endothelium by P-selectin is an important early consequence of reperfusion injury, and a specific monoclonal antibody to P-selectin exerts significant endothelial preservation and cardioprotection in myocardial ischemia and reperfusion.
authors.affiliation: Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107-6799.
authors.forename: A S
authors.initials: AS
authors.lastname: Weyrich
authors.forename: X Y
authors.initials: XY
authors.lastname: Ma
authors.forename: D J
authors.initials: DJ
authors.lastname: Lefer
authors.forename: K H
authors.initials: KH
authors.lastname: Albertine
authors.forename: A M
authors.initials: AM
authors.lastname: Lefer
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D001792:Blood Platelets / Q000378:metabolism; D002415:Cats; D002448:Cell Adhesion / Q000187:drug effects; D015815:Cell Adhesion Molecules / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism*; D004594:Electrophysiology; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000473:pathology; D005434:Flow Cytometry; D005786:Gene Expression Regulation; D006321:Heart / Q000503:physiopathology*; D006439:Hemodynamics; D007150:Immunohistochemistry; D008297:Male; D015428:Myocardial Reperfusion Injury / Q000188:drug therapy*; D009500:Neutralization Tests; D009504:Neutrophils / Q000378:metabolism; D019007:P-Selectin; D010974:Platelet Aggregation / Q000187:drug effects; D010980:Platelet Membrane Glycoproteins / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D015815:Cell Adhesion Molecules; D019007:P-Selectin; D010980:Platelet Membrane Glycoproteins